Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes (2008) 2.25

Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2008) 1.98

Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther (2010) 1.95

How mesenchymal stem cells interact with tissue immune responses. Trends Immunol (2012) 1.92

Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica (2008) 1.87

Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol (2008) 1.74

Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med (2011) 1.72

Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2011) 1.66

Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61

Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells (2011) 1.61

Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol (2010) 1.56

Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation (2013) 1.53

Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) (2011) 1.46

Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med (2013) 1.44

Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev (2012) 1.44

Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int (2012) 1.41

Allogeneic periodontal ligament stem cell therapy for periodontitis in swine. Stem Cells (2010) 1.40

Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy (2009) 1.35

Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm (2010) 1.33

Human adipose-derived cells: an update on the transition to clinical translation. Regen Med (2012) 1.33

Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease. Stem Cells (2011) 1.29

Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One (2012) 1.28

Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells (2010) 1.27

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med (2008) 1.27

Concise review: adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical implications for tissue engineering therapies in regenerative surgery. Stem Cells Transl Med (2012) 1.25

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci (2011) 1.20

Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica (2013) 1.17

Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) (2008) 1.17

Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus. Stem Cells Int (2010) 1.15

Mesenchymal stromal cells: a new tool against graft-versus-host disease? Biol Blood Marrow Transplant (2011) 1.11

Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther (2009) 1.11

The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. Br J Radiol (2010) 1.10

Toll-like receptors as modulators of mesenchymal stem cells. Front Immunol (2012) 1.09

Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res (2014) 1.09

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell Immunol (2011) 1.08

Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem Cells Dev (2013) 1.08

Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol Ther (2009) 1.07

Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells (2013) 1.06

Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. Am J Stem Cells (2013) 1.05

Adipose tissue stem cells: the great WAT hope. Trends Endocrinol Metab (2012) 1.05

Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Eng Part A (2010) 1.05

Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation. Biol Blood Marrow Transplant (2010) 1.04

Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis (2016) 1.03

Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage. PLoS One (2013) 1.02

Adipose-derived stem cell delivery into collagen gels using chitosan microspheres. Tissue Eng Part A (2010) 1.02

Neuron-like differentiation of adipose-derived stem cells from infant piglets in vitro. J Spinal Cord Med (2007) 1.02

Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand? World J Stem Cells (2011) 1.01

Mesenchymal stem cells: from biology to clinical use. Blood Transfus (2007) 1.00

Stem cell therapy: a novel & futuristic treatment modality for disaster injuries. Indian J Med Res (2012) 1.00

Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials. Stem Cells Int (2010) 0.99

Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol (2009) 0.99

Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species. Cell Death Differ (2013) 0.99

Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia (2014) 0.99

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med (2011) 0.99

Stem cell treatment of degenerative eye disease. Stem Cell Res (2015) 0.99

Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood (2009) 0.98

Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease. Adv Hematol (2011) 0.97

The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice. Immunology (2011) 0.96

Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy. Adv Pharm Bull (2013) 0.96

Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers. Stem Cells Int (2013) 0.96

Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells. Biomed Res Int (2014) 0.95

Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model. J Orthop Res (2009) 0.95

The therapeutic effect of human adult stem cells derived from adipose tissue in endotoxemic rat model. Int J Med Sci (2012) 0.94

Immunogenicity of allogeneic adipose-derived stem cells in a rat spinal fusion model. Tissue Eng Part A (2009) 0.93

Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy. Stem Cells Cloning (2011) 0.93

Controlled delivery of mesenchymal stem cells and growth factors using a nanofiber scaffold for tendon repair. Acta Biomater (2013) 0.93

Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? Biomed Res Int (2014) 0.92

Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant (2009) 0.92

Immunomodulatory effects of adipose-derived stem cells: fact or fiction? Biomed Res Int (2013) 0.92

From bench to bedside: use of human adipose-derived stem cells. Stem Cells Cloning (2015) 0.91

Mesenchymal stem cell-derived hepatocytes for functional liver replacement. Front Immunol (2012) 0.91

Adipose tissue as a stem cell source for musculoskeletal regeneration. Front Biosci (Schol Ed) (2011) 0.90

Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther (2013) 0.90

Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial. Stem Cells Transl Med (2016) 0.89

Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J Am Soc Nephrol (2013) 0.89

Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro. Croat Med J (2009) 0.89

Adipose-derived stromal/stem cells: a primer. Organogenesis (2013) 0.89

Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells (2015) 0.89

Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy. J Biomed Biotechnol (2012) 0.89

Emerging therapeutic approaches for multipotent mesenchymal stromal cells. Curr Opin Hematol (2010) 0.88

Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J Transl Med (2010) 0.87

Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model. J Stem Cell Res Ther (2013) 0.87

Derivation, expansion and characterization of clinical grade mesenchymal stem cells from umbilical cord matrix using cord blood serum. Int J Stem Cells (2010) 0.87

Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease. Expert Opin Pharmacother (2008) 0.87

Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease. Immune Netw (2013) 0.87

Concise review: therapeutic potential of adipose tissue-derived angiogenic cells. Stem Cells Transl Med (2012) 0.87

Adipose-derived mesenchymal stromal cells modulate tendon fibroblast responses to macrophage-induced inflammation in vitro. Stem Cell Res Ther (2015) 0.86

Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase. Front Immunol (2012) 0.86

Immune Modulation by Mesenchymal Stem Cells. Transfus Med Hemother (2008) 0.86

Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies. Arch Immunol Ther Exp (Warsz) (2016) 0.86

Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. Stem Cells (2015) 0.85

Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells. Stem Cells (2015) 0.85

A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses. PLoS One (2013) 0.85

Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro. PLoS One (2011) 0.84

Regenerative pulmonary medicine: potential and promise, pitfalls and challenges. Eur J Clin Invest (2012) 0.84

The use of adipose stem cells in cranial facial surgery. Stem Cell Rev (2014) 0.84

PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma. Mol Cancer (2014) 0.83

Adipose derived mesenchymal stem cells efficiently rescue carbon tetrachloride-induced acute liver failure in mouse. ScientificWorldJournal (2014) 0.83

Phenotypic characterizations and comparison of adult dental stem cells with adipose-derived stem cells. Int J Prev Med (2010) 0.83

Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes? Stem Cells Int (2011) 0.83

Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet (2013) 2.15

Infantile transient smooth muscle contraction of the skin. J Am Acad Dermatol (2013) 1.95

Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther (2010) 1.42

Dopamine mobilizes mesenchymal progenitor cells through D2-class receptors and their PI3K/AKT pathway. Stem Cells (2014) 1.41

Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther (2006) 1.39

Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med (2009) 1.31

A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network. J Med Genet (2006) 1.30

Erythema dyschromicum perstans in children: a report of 14 cases. J Eur Acad Dermatol Venereol (2005) 1.25

Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol (2010) 1.25

Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res (2010) 1.24

Hobnail hemangioma reclassified as superficial lymphatic malformation: a study of 52 cases. J Am Acad Dermatol (2011) 1.22

Effects of an intrahospital exercise program intervention for children with leukemia. Med Sci Sports Exerc (2007) 1.19

Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood (2011) 1.18

Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16

Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-beta and IGF-II. Cell Res (2009) 1.14

Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology (2006) 1.13

Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. Cancer Res (2010) 1.13

Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells. Mol Ther (2010) 1.11

KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors. Pediatr Blood Cancer (2009) 1.11

Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia (2009) 1.09

FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells. Stem Cells (2011) 1.07

Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol Ther (2009) 1.07

An immunohistochemical study of verrucous hemangiomas. J Cutan Pathol (2013) 1.06

A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood (2004) 1.05

A new wine Saccharomyces cerevisiae killer toxin (Klus), encoded by a double-stranded rna virus, with broad antifungal activity is evolutionarily related to a chromosomal host gene. Appl Environ Microbiol (2011) 1.05

Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy. Mol Ther (2007) 1.04

Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors. Blood (2008) 1.02

Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. J Virol (2003) 1.01

Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. Exp Cell Res (2004) 1.01

In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice. Blood (2002) 1.00

Predictors of blood transfusion in patients undergoing elective surgery for degenerative conditions of the spine. Arch Orthop Trauma Surg (2012) 0.97

Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme. Mol Ther (2009) 0.97

Early-phase adaptations to intrahospital training in strength and functional mobility of children with leukemia. J Strength Cond Res (2007) 0.97

In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1. Blood (2008) 0.95

Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One (2011) 0.94

Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol (2012) 0.94

Fatal hepatic failure secondary to acute herpes simplex virus infection. J Pediatr Hematol Oncol (2004) 0.94

Pyoderma gangrenosum in an infant. Pediatr Dermatol (2006) 0.93

Physical activity during treatment in children with leukemia: a pilot study. Appl Physiol Nutr Metab (2006) 0.93

Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet (2011) 0.93

Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol (2011) 0.92

Wine yeast molecular typing using a simplified method for simultaneously extracting mtDNA, nuclear DNA and virus dsRNA. Food Microbiol (2009) 0.91

Persistent agmination of lymphomatoid papulosis. Pediatr Dermatol (2010) 0.91

Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors. Cancer Gene Ther (2005) 0.91

Exercise during hematopoietic stem cell transplant hospitalization in children. Med Sci Sports Exerc (2010) 0.91

Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J Biol Chem (2009) 0.90

Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia. Hum Gene Ther (2010) 0.90

Lentiviral vector integration sites in human NOD/SCID repopulating cells. J Gene Med (2006) 0.90

Nevus psiloliparus and aplasia cutis: a further possible example of didymosis. Pediatr Dermatol (2005) 0.89

Systemic juvenile xanthogranuloma with fatal outcome. Pediatr Dermatol (2010) 0.88

Neonatal functional intestinal obstruction and the presence of severely immature ganglion cells on rectal biopsy: 6 year experience. Pediatr Surg Int (2011) 0.88

Generation of functional neutrophils from a mouse model of X-linked chronic granulomatous disorder using induced pluripotent stem cells. PLoS One (2011) 0.88

Hereditary mucoepithelial dysplasia: report of two sporadic cases. Pediatr Dermatol (2011) 0.88

Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase. PLoS One (2012) 0.88

Folliculocystic and collagen hamartoma of tuberous sclerosis complex. J Am Acad Dermatol (2011) 0.88

In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells. Exp Hematol (2003) 0.88

Deep morphea after vaccination in two young children. Pediatr Dermatol (2006) 0.87

Electron microscopy reveals the presence of viruses in mouse embryonic fibroblasts but neither in human embryonic fibroblasts nor in human mesenchymal cells used for hESC maintenance: toward an implementation of microbiological quality assurance program in stem cell banks. Cloning Stem Cells (2008) 0.87

Disseminated congenital comedones. Pediatr Dermatol (2011) 0.87

Rhodamine-pink as a genetic marker for yeast populations in wine fermentation. J Agric Food Chem (2006) 0.87

Rapid asymmetrical evolution of Saccharomyces cerevisiae wine yeasts. Yeast (2005) 0.86

Sulfometuron resistance as a genetic marker for yeast populations in wine fermentations. J Agric Food Chem (2005) 0.86

Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2010) 0.85

Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin. Mol Cancer Ther (2008) 0.85

Down-regulated expression of hsa-miR-181c in Fanconi anemia patients: implications in TNFα regulation and proliferation of hematopoietic progenitor cells. Blood (2012) 0.84

Papular epidermal nevus with "skyline" basal cell layer (PENS). J Am Acad Dermatol (2011) 0.84

Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells. Stem Cells (2014) 0.84

Papular epidermal nevus with "skyline" basal cell layer (PENS) with extracutaneous findings. Pediatr Dermatol (2012) 0.84

The mobilization of hematopoietic progenitors to peripheral blood is predictive of the hematopoietic syndrome after total or partial body irradiation of mice. Int J Radiat Oncol Biol Phys (2006) 0.83

Characterization, ecological distribution, and population dynamics of Saccharomyces sensu stricto killer yeasts in the spontaneous grape must fermentations of southwestern Spain. Appl Environ Microbiol (2011) 0.83

Preliminary findings of a 4-month intrahospital exercise training intervention on IGFs and IGFBPs in children with leukemia. J Strength Cond Res (2010) 0.83

Nucleocytoplasmic shuttling of STK16 (PKL12), a Golgi-resident serine/threonine kinase involved in VEGF expression regulation. Exp Cell Res (2005) 0.83

In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity. Mol Ther (2010) 0.83

Evolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism. J Virol (2007) 0.82

Brain aminopeptidases and hypertension. J Renin Angiotensin Aldosterone Syst (2006) 0.82

Use of CFU-GM assay for prediction of human maximum tolerated dose of a new antitumoral drug: Yondelis (ET-743). Toxicol In Vitro (2003) 0.81

Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats. PLoS One (2012) 0.81

Usefulness of the core outcome measures index in daily clinical practice for assessing patients with degenerative lumbar disease. Adv Orthop (2012) 0.81

Cutaneous aspergillosis mimicking pancreatic and gouty panniculitis. J Am Acad Dermatol (2012) 0.81

Dermatomyofibromas presenting in pediatric patients: clinicopathologic characteristics and differential diagnosis. J Cutan Pathol (2011) 0.81

Brief report: impaired cell reprogramming in nonhomologous end joining deficient cells. Stem Cells (2013) 0.81

Mesenchymal niches of bone marrow in cancer. Clin Transl Oncol (2011) 0.81

Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Adv Exp Med Biol (2012) 0.81

Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells. PLoS One (2010) 0.81

Exercise benefits in chronic graft versus host disease: a murine model study. Med Sci Sports Exerc (2013) 0.81

Malignant atrophic papulosis: a case report with severe visual and neurological impairment. Pediatr Dermatol (2010) 0.81

Epidermolysis bullosa simplex with mottled pigmentation: a family report and review. Pediatr Dermatol (2012) 0.81

Analysis of homothallic Saccharomyces cerevisiae strain mating during must fermentation. Appl Environ Microbiol (2007) 0.81

Poor outcomes and satisfaction in adolescent idiopathic scoliosis surgery: the relevance of the body mass index and self-image. Eur Spine J (2014) 0.81

Alcohol consumption in the EU: health economics and policy issues under a permanent debate. Eur J Health Econ (2008) 0.80

Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa. J Neurol Sci (2005) 0.80

Fanconi anaemia: from a monogenic disease to sporadic cancer. Clin Transl Oncol (2011) 0.80

Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients. Cancer Res (2002) 0.80

Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review. Pediatr Dermatol (2013) 0.79